Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
---|
06/12/2013 | EP2602242A1 Process for preparing compound by novel sandmeyer-like reaction using nitroxide radical compound as reaction catalyst |
06/12/2013 | EP2601951A1 Pharmaceutical composition for treating hemorrhage caused by blood clotting disorder and use thereof |
06/12/2013 | EP2601946A1 Treatment and prevention of diseases related to oxidative stress |
06/12/2013 | EP2601189A1 N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides as inhibitors of plasma kallikrein |
06/12/2013 | EP2600865A1 Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound |
06/12/2013 | CN1461310B ANtibodies that bind human interleukin-18 and methods of making and using |
06/12/2013 | CN103153977A Organic amine salt of aminobenzoic acid derivative, and method for producing same |
06/12/2013 | CN103153306A Solid dispersion comprising triazole compound |
06/12/2013 | CN103153299A Prophylactic and/or therapeutic agent against lymphedema |
06/12/2013 | CN103153296A Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists |
06/12/2013 | CN103146668A Preparation technology of lumbrukinase dry powder |
06/12/2013 | CN103145868A Derivate of low molecular weight fucosylated glycosaminoglycan and medical composition and preparation method and application thereof |
06/12/2013 | CN103145800A Centipede zymolyte anti-thrombus polypeptide |
06/12/2013 | CN103145797A [(3s)-1,2,3,4-tetrahydroisoquinoline-3-formoxy]-Lys modified RGD tetrapeptide and its synthesis method and use in medical science |
06/12/2013 | CN103145774A Anticoagulation pentose and preparation method thereof |
06/12/2013 | CN103145738A Imidazo [2,1-b] thiayole derivatives as SIRTUIN modulating compounds |
06/12/2013 | CN103145679A Preparation method and application of epigallocatechin gallate |
06/12/2013 | CN103145603A Carbazochrome sodium sulfonate compound and medical composition thereof |
06/12/2013 | CN103142866A Traditional Chinese medicine composition for treating cardia-cerebrovascular disease and preparation method thereof |
06/12/2013 | CN103142853A Medicament for treating aplastic anemia |
06/12/2013 | CN103142826A Poison yam strangury freeing tablet |
06/12/2013 | CN103142816A Externally applied traditional Chinese medicine wine and making method thereof |
06/12/2013 | CN103142798A Guiqi blood-nourishing dispersible tablet used for regulating menstruation and tonifying blood, and preparation method thereof |
06/12/2013 | CN103142759A Oral liquid capable of complementing vital essence and tonifying Qi and nourishing blood and tranquilization |
06/12/2013 | CN103142751A Traditional Chinese medicine composition for treating piglet iron-deficiency anemia |
06/12/2013 | CN103142728A Pure herbal heat-clearing oral liquid and preparation method thereof |
06/12/2013 | CN103142726A Ulcer hemorrhage stopping powder |
06/12/2013 | CN103142721A Method for extracting triterpenoid from anli pear |
06/12/2013 | CN103142690A Rabdosia rubescens stem aqueous extract and its preparation method, finger-prints and use as antithrombotic agent |
06/12/2013 | CN103142681A Flemingia philippinensis total flavonoids and beta-cyclodextrin clathrate compound and preparation method thereof |
06/12/2013 | CN103142669A Enzyme method for extracting ginsenoside and obtained ginsenoside extractive |
06/12/2013 | CN103142662A Method for extracting and purifying polyphenol from choerospondias axillaris peel |
06/12/2013 | CN103142650A Preparation and composition of inner-alpha inhibitor protein from human plasma for treatment |
06/12/2013 | CN103142618A Metroprolol succinate hydrochlorothiazide sustained-release pellet capsule and preparation method thereof |
06/12/2013 | CN103142605B Novel use of doxofylline compound |
06/12/2013 | CN103142605A Novel use of doxofylline compound |
06/12/2013 | CN103142602A Application of allopurinol in preparing medicines after atrial fibrillation catheter ablation |
06/12/2013 | CN103142586A 治疗疾病的疗法 Treatment of disease therapy |
06/12/2013 | CN103142579A Salvianolic acid A freeze-dried powder and application thereof to medicine preparation |
06/12/2013 | CN103142578A Salvianolic acid A freeze-dried powder and application thereof to medicine preparation |
06/12/2013 | CN103142577A Salvianolic acid A composition and application thereof to medicine preparation |
06/12/2013 | CN103142576A Application of salvianolic acid A freeze-dried powder to preparation of drug for protecting cerebral vascular endothelial cells |
06/12/2013 | CN103142575A Application of salvianolic acid A freeze-dried powder to preparation of drug for inhibiting neuronal damage or death of brain tissue |
06/12/2013 | CN103142574A Salvianolic acid A freeze-dried powder and application thereof to medicine preparation |
06/12/2013 | CN103142573A Application of salvianolic acid A freeze-dried powder to preparation of drug for improving symptom of neurological function after cerebral ischemia |
06/12/2013 | CN103142572A Salvianolic acid A tablet and application thereof to medicine preparation |
06/12/2013 | CN103142571A Salvianolic acid A composition and application thereof to medicine preparation |
06/12/2013 | CN103142566A Important-protein inhibitor in severe fever with thrombocytopenia syndrome |
06/12/2013 | CN103142557A Polymannuronate sulfate slow release capsule and preparation method thereof |
06/12/2013 | CN103142556A Polysaccharide sulfate sustained-release capsule and preparation method thereof |
06/12/2013 | CN103142549A Mannose ester enteric capsule and preparation method thereof |
06/12/2013 | CN103142544A Ubenimex capsule composition and preparation method thereof |
06/12/2013 | CN103142543A Salvianolic acid A capsule and application thereof to medicine preparation |
06/12/2013 | CN103142542A Salvianolic acid A capsule and application thereof to medicine preparation |
06/12/2013 | CN103142540A PGMS (Propylene Glycol Mannate Sulfate) controlled-release tablet and preparation method thereof |
06/12/2013 | CN103142539A Alginic sodium diester controlled-release tablet and preparation method thereof |
06/12/2013 | CN103142538A PGMS (Propylene Glycol Mannate Sulfate) enteric tablet and preparation method thereof |
06/12/2013 | CN103142535A Alginic sodium diester enteric tablet and preparation method thereof |
06/12/2013 | CN103142517A Salvianolic acid A dropping pill and application thereof to medicine preparation |
06/12/2013 | CN103142516A Salvianolic acid A dropping pill and application thereof to medicine preparation |
06/12/2013 | CN103142509A Bortezomib pharmaceutic composition for injection |
06/12/2013 | CN103142504A PGMS (Propylene Glycol Mannate Sulfate) sustained-release granule and preparation method thereof |
06/12/2013 | CN103142474A Composition taking high-purity ginkgolide B as active ingredient and preparation method thereof |
06/12/2013 | CN103142473A Composition containing high purity bilobalide B and preparation method thereof |
06/12/2013 | CN103142472A Ginkgolide B composition and preparation method thereof |
06/12/2013 | CN102652755B Mannitol sodium chloride injection and preparation method thereof |
06/12/2013 | CN102580058B Therapeutic agent for blood-related disease containing epo derivative |
06/12/2013 | CN102579897B Medicine for treating postoperative uroschesis of anorectal diseases and preparation method thereof |
06/12/2013 | CN102579503B Method for separating skin of eupolyphaga egg clamp from egg inside eupolyphaga egg clamp |
06/12/2013 | CN102552808B Medicament for treating vaginal bleeding after abortion |
06/12/2013 | CN102552308B Application of campsis radicans polysaccharide to preparation of anticoagulant medicines |
06/12/2013 | CN102526411B Chinese medicinal composition for treating surgical wound |
06/12/2013 | CN102441156B Traditional Tibetan medicinal composition and preparation method thereof |
06/12/2013 | CN102378814B Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof |
06/12/2013 | CN102370896B Medicine for treating cerebral thrombosis |
06/12/2013 | CN102309539B Spina gleditsiae extract hydrogel patch and preparation method thereof |
06/12/2013 | CN102302667B Traditional Chinese medicinal pills for treating iron-deficiency anemia (IDA) |
06/12/2013 | CN102293791B Production method for extracting effective components of gingko leaf |
06/12/2013 | CN102250737B Wine with health-care effect |
06/12/2013 | CN102241728B Steroid sapogenin derivatives and preparation method and application thereof |
06/12/2013 | CN102234284B Fluorine-containing ticlopidine analogues, and preparation method and application thereof |
06/12/2013 | CN102090622B Sparassia crispa(Wulf.)Fr. solution preparation method |
06/12/2013 | CN102060787B Tetramethylpyrazine ferulate crystals for suppressing platelet aggregation and thrombosis and preparation method thereof |
06/12/2013 | CN101993376B Caffeic acid p-nitrophenyl ethyl ester as well as preparation method and application of caffeic acid p-nitrophenyl ethyl ester |
06/12/2013 | CN101983072B Mineral absorption accelerator and iron deficiency anemia improver or food composition |
06/12/2013 | CN101870735B High-glycosylation erythropoietin immune fusion protein |
06/12/2013 | CN101678031B Formulations containing triazinones and iron |
06/12/2013 | CN101549005B Application of Acacia catechu (L.) wild extract to medicines capable of improving white blood cells |
06/12/2013 | CN101472577B Infusion preparation for dialysis patient |
06/11/2013 | US8461139 Oral suspension of prednisolone acetate |
06/11/2013 | US8461116 Liquid composition of factor VII polypeptides |
06/11/2013 | US8461109 Method of enhancing the acceptance and/or healing of a skin graft |
06/11/2013 | US8460706 Hydrophilic/lipophilic polymeric matrix dosage formulation |
06/11/2013 | CA2484209C Protein kinase modulators and methods of use |
06/11/2013 | CA2437064C Storage-stable, liquid fibrinogen formulation |
06/06/2013 | WO2013082282A1 Anti-il-1beta (interleukin-1beta) antibody-based prophylactic therapy to prevent complications leading to vaso-occlusion in sickle cell disease. |
06/06/2013 | WO2013082210A1 Anticoagulant reversal agents |
06/06/2013 | WO2013081118A1 Compound having read-through activity |
06/06/2013 | WO2013081016A1 Purinone derivative hydrochloride |
06/06/2013 | WO2013079589A1 Novel crystalline form of ticagrelor and process for the preparation thereof |